
TeleZen MD Review
Best for: claimed all-50-state compounded GLP-1 access with $100-off first order
TeleZen MD (telezenmd.com) is a 100% online U.S. telehealth platform offering GLP-1 therapy via U.S.-based FDA-registered pharmacies. The provider claims operation in 'all 50 U.S. states, subject to medical eligibility and state regulations.' First-time visitors are offered $100 off their first order with code WELCOME100. Steady-state monthly pricing is not disclosed on the marketing home page.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
TeleZen MD is a solid telehealth option with balanced features and pricing.
TeleZen MD at a glance
- Type
- GLP-1 telehealth provider
- Starting price
- $198/mo ($148 first month, $198/month after. Multi-month plans (paid in full): quarterly $166/mo ($498), semi-annual $149/mo ($898), annual $133/mo ($1598). Prices are estimated monthly-equivalent of the 3-/6-month plans.)
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored TeleZen MD
Each dimension is scored algorithmically from TeleZen MD’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.3/10TeleZen MD does not post a standard monthly cash price up front, so cost transparency is limited — confirm the ongoing rate before you commit.
Effectiveness25%
8.1/10TeleZen MD offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.1/10Online intake and platform experience — consult included in the price; 3 platform features disclosed.
Trust & Safety15%
7.3/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-06-06).
Accessibility10%
6.1/10TeleZen MD's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
5.9/10TeleZen MD provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this TeleZen MD review
Last checked 2026-06-06- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications TeleZen MD offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
$148 first month, $198/month after. Multi-month plans (paid in full): quarterly $166/mo ($498), semi-annual $149/mo ($898), annual $133/mo ($1598). Prices are estimated monthly-equivalent of the 3-/6-month plans.
$248 first month, $298/month after. Multi-month plans (paid in full): quarterly $249/mo ($748), semi-annual $233/mo ($1398), annual $216/mo ($2598).
Ready to get started?
Plans and promotions change often — check TeleZen MD's current pricing and active discounts before you decide.
What we like
- Says it serves all 50 states — among the broadest claimed reach in the compounded segment
- Markets U.S.-based, FDA-registered pharmacies
- $100 off your first order with code WELCOME100
- Fully online U.S. telehealth model with physician evaluation
- Education-forward, physician-led positioning
- Plan pricing now published: compounded GLP-1 from $133/mo, GLP-1+GIP from $216/mo (annual prepay); 180-day guarantee
Watch-outs
- Partner pharmacy not named
- Legal entity name and state of incorporation not disclosed
- Brand-name medications not addressed on the homepage
- LegitScript certification not confirmed
- All-50-states claim is the provider's own, not independently verified
- Medication forms (vial, pen, oral) not detailed
- Lowest advertised rates ($133/mo sema, $216/mo tirz) require paying a full 6- or 12-month plan in full at checkout
TeleZen MD, reviewed: a founder-led Florida telehealth bet on commitment pricing
TeleZen MD is a fully online, cash-pay GLP-1 program that wants you to think in months, not weeks. The pitch from co-founders Lina and Eric Viner is a physician-guided compounded weight-loss plan paired with a habit-change curriculum the company calls Lose It for Life, sold the way a gym sells memberships: the longer you commit up front, the less you pay each month. If you already know you're in this for the long haul and you're comfortable prepaying, the math can work in your favor. If you want to try a month and walk away cheaply, this isn't the gentlest place to do it.
How the pricing actually works (and where the lowest number hides)
TeleZen MD publishes its rates openly, which already puts it ahead of the many compounders that hide pricing behind an intake quiz. The structure is the catch. Its compounded semaglutide plan runs on a month-to-month subscription with a discounted first month and a higher steady rate after that. But the headline figure the site leads with, the eye-catching low monthly cost, isn't the month-to-month price at all. It's the per-month equivalent of the annual plan, which you pay for in one lump sum at checkout. Quarterly and semi-annual prepay options sit in between.
- Month-to-month: lowest commitment, highest per-month cost; a reduced first month then the standard ongoing rate.
- Quarterly / semi-annual: a meaningful per-month discount, billed in full at the start of the term.
- Annual: the cheapest per-month number TeleZen advertises, but it requires paying a full year up front in a single charge.
Read the fine print and you'll see the company's own disclaimer: all multi-month plans are paid in full at checkout, and the per-month figures are estimates of the prepaid plans' monthly equivalent. So the friendly number on the landing page is real, but only if you're willing to put a four-figure sum on the table on day one. New patients can knock a flat amount off the first order with the code WELCOME100. For context, the category median ongoing price we track sits around $169, and TeleZen's standard month-to-month rate lands above that, with the savings only appearing once you prepay.
The medications and how they're dispensed
There are two tracks. The GLP-1 plan is compounded semaglutide; the GLP-1 plus GIP plan is compounded tirzepatide, which costs more at every tier. Both come from what TeleZen describes as U.S.-based, FDA-registered 503A compounding pharmacies. Everything is cash-pay: there's no insurance billing, but plans are FSA- and HSA-eligible, and the checkout supports buy-now-pay-later services like Klarna, Affirm, and Afterpay, which softens the blow of those upfront prepay charges. Each plan bundles the medication, the physician consult and ongoing oversight, and free discreet shipping, so the monthly number is meant to be all-in rather than a base price with add-ons stacked on later.
One honest gap: the site doesn't spell out the medication forms. Whether you're getting vials and syringes versus a pen, and the exact dosing ladder, isn't detailed publicly. Brand-name Wegovy, Ozempic, Zepbound, or Mounjaro aren't part of the lineup either. This is a compounded-only, cash-pay program, full stop.
What actually sets TeleZen apart
Two things genuinely distinguish it. First, the all-50-states claim. TeleZen says it operates in every U.S. state subject to eligibility and state rules, which would make its footprint among the broadest in the compounded segment. We treat that as the provider's own claim rather than something we've independently confirmed, so weigh it accordingly. Second, the company leans hard into being founder-led and physician-fronted. It names its co-founders, names individual doctors involved in care (Dr. James Teet, Dr. Ozita Cooper, Dr. Michael Wasef, and Dr. Andrew Sakla), and reports having served more than a hundred thousand patients. That transparency about who's behind the brand is more than a lot of faceless compounders offer.
The Lose It for Life program is the other differentiator. It's a behavior-change layer aimed at the habits underneath the weight, included at no extra charge with every plan. Whether it earns its advertised value is subjective, but a structured coaching component bundled in, rather than sold separately, is a reasonable reason to pick TeleZen over a bare medication-only competitor.
Trust and oversight: solid model, unconfirmed specifics
The reassuring news: there are no FDA warning letters on file for TeleZen MD, and the platform is clearly live, physician-staffed, and openly priced. It backs plans with a 180-day guarantee, which is a longer safety net than most. The caveats are about what we can't verify. The specific partner pharmacy isn't named. The legal entity and state of incorporation aren't disclosed beyond a stated Florida base. And the pharmacies are described only as FDA-registered, which is a different and lower bar than LegitScript certification; we couldn't confirm LegitScript status. Our confidence is medium on the platform and its telehealth model, and lower on the independently verified specifics. See our scoring methodology for how we weigh claims we can't confirm.
Who should choose it, and who should skip it
- Good fit: committed patients who want compounded semaglutide or tirzepatide, are comfortable prepaying for the lowest per-month rate, value a bundled habit-change program, and want HSA/FSA or pay-over-time options.
- Think twice: anyone who wants to test the waters one month at a time, needs brand-name medication, requires a named and LegitScript-certified pharmacy before committing, or isn't comfortable paying a large sum up front to unlock the advertised price.
Bottom line
TeleZen MD is a credible, transparent-on-price compounded GLP-1 option with an unusually broad claimed reach, real named clinicians, and a coaching program built in. Its weakness isn't hype, it's commitment: the attractive headline rate is a prepaid annual figure, and several trust details, the pharmacy partner, the corporate entity, LegitScript status, remain unconfirmed. If you're ready to commit and prepay, it's worth a serious look. If you want a low-risk first month or independently verified pharmacy credentials, start somewhere you can confirm those things first.
Ready to start with TeleZen MD?
Starting at $198/month. See current pricing and start your free consultation.
Alternatives to TeleZen MD
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this TeleZen MD review:
Sources & methodology — as of June 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with TeleZen MD?
Starting at $198/month. See current pricing and start your free consultation.